Clinical Trials Arena July 9, 2025
With artificial intelligence (AI) fast becoming an ubiquitous part of everyday life, its further application in clinical trials holds considerable promise.
Artificial intelligence (AI) should soon be taking a greater role in areas including patient recruitment and in building efficiencies around data quality.
That is the hope among those attending this year’s Clinical Trials in Oncology (CTO) East Coast 2025 conference, taking place on 8-9 July in Boston.
During an interview with Clinical Trials Arena, Leena Gandhi, chief medical officer at NextPoint Therapeutics, believes that AI will have an increasing role on the operational side with regard to modifying trial protocols in responding to changes as a trial unfolds.
“I don’t think AI will get us away from learning what...
Today's Sponsors
Today's Sponsor